Ms Dawn Marie Schull, LADC | |
408 W Fountain St, Albert Lea, MN 56007-2437 | |
(507) 377-6411 | |
(507) 377-6793 |
Full Name | Ms Dawn Marie Schull |
---|---|
Gender | Female |
Speciality | Counselor - Addiction (substance Use Disorder) |
Location | 408 W Fountain St, Albert Lea, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982130852 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YA0400X | Counselor - Addiction (substance Use Disorder) | 302737 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Dawn Marie Schull, LADC 408 W Fountain St, Albert Lea, MN 56007-2437 Ph: (507) 377-6411 | Ms Dawn Marie Schull, LADC 408 W Fountain St, Albert Lea, MN 56007-2437 Ph: (507) 377-6411 |
News Archive
Looking to spice up your sex life? Try adding ginseng and saffron to your diet. Both are proven performance boosters, according to a new scientific review of natural aphrodisiacs conducted by University of Guelph researchers.
New research suggests that one of the most common causes of vision loss could be avoided by eating food rich in omega-3 fatty acids.
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida, the German Cancer Research Center in Heidelberg, and the International Agency for Research on Cancer in Lyon, France, conducted a case control study and found associations between having antibodies to certain types of cutaneous human papillomavirus (HPV) and a kind of skin cancer called squamous cell carcinoma (SCC).
Researchers across 13 European and African research institutes will work together to integrate data from climate modelling and disease forecasting systems to predict the likelihood of an epidemic up to six months in advance. The research, funded by the European Commission Seventh Framework programme, will focus on climate and disease in Senegal, Ghana and Malawi and aims to give decision makers the necessary time to deploy intervention methods to help prevent large scale spread of diseases such as Rift Valley Fever and malaria.
Roche Canada announced today that Health Canada has approved AVASTIN(R) (bevacizumab), as a single agent, for the treatment of patients with glioblastoma multiforme, the most aggressive primary malignant brain tumour, after relapse or disease progression, following prior therapy.
› Verified 8 days ago
Corinne Marie Applegate, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 905 Blackmer Ave, Albert Lea, MN 56007 Phone: 507-373-9867 | |
Ms. Judith A Popp Anderson, LICSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 203 W Clark St, Albert Lea, MN 56007 Phone: 507-377-5440 Fax: 507-377-5498 | |
Erica Haugh, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 408 W Fountain St, Albert Lea, MN 56007 Phone: 507-377-6411 Fax: 507-377-6443 | |
Joseph Petersen, BS, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 203 W Clark St, Albert Lea, MN 56007 Phone: 507-377-5484 Fax: 507-377-5505 | |
Melissa Tindal, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 408 W Fountain St, Albert Lea, MN 56007 Phone: 507-377-6411 | |
Wilhelmina Christina Olivier, Counselor Medicare: Not Enrolled in Medicare Practice Location: 924 Bridge Ave, Albert Lea, MN 56007 Phone: 507-450-4310 | |
Taylor Stone, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 408 W Fountain St, Albert Lea, MN 56007 Phone: 507-377-6411 Fax: 507-377-6334 |